Supernus Pharmaceuticals reported $215.28M in Cash and Equivalent for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Adamas Pharmaceuticals ADMS:US 78.62M 10.17M
Aerie Pharmaceuticals AERI:US $ 61.85M 18.11M
Ani Pharmaceuticals ANIP:US $ 15.25M 9.01M
Aurora Cannabis Inc ACB:CN 372.79M 48.67M
Bristol Myers Squibb BMY:US $ 13540M 2516M
Canopy Growth Corp WEED:CN C$ 807.62M 615.06M
Cara Therapeutics CARA:US $ 22.99M 656K
Corcept Therapeutics CORT:US $ 94.69M 0.74M
Eisai 4523:JP Y 283002M 69920M
Eli Lilly And LLY:US $ 3788.2M 568.2M
Endo International Ordinary Shares ENDP:US $ 1568.66M 23.49M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Horizon Pharma HZNP:US $ 1068.55M 256.23M
Jazz Pharmaceuticals JAZZ:US 1000 0
Lannett LCI:US $ 105.32M 12.04M
Marinus Pharmaceuticals MRNS:US $ 145.1M 32.61M
Pacira Pharmaceuticals PCRX:US $ 134.04M 28.26M
Perrigo Ordinary Shares PRGO:US $ 2078.1M 1760.6M
Revance Therapeutics RVNC:US $ 127.18M 40.46M
Supernus Pharmaceuticals SUPN:US $ 215.28M 8.49M
Teva Pharmaceutical Industries TEVA:US $ 2045M 391M
United Therapeutics UTHR:US $ 908.5M 33.7M
Xeris Pharmaceuticals Inc XERS:US $ 59.49M 4.11M